Retour
Fourchette du Jour
1,67 €
1,72 €
Fourchette 52 Semaines
1,24 €
3,34 €
Volume
200
Moyenne 50J / 200J
1,92 €
/
2,04 €
Clôture Précédente
1,53 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -11,1 | 0,4 |
| P/B | 3,5 | 2,9 |
| ROE % | -27,7 | 3,7 |
| Net Margin % | -64,9 | 3,9 |
| Rev Growth 5Y % | 13,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,10 €
0,09 € – 0,12 €
|
700 M | 1 |
| FY2029 |
0,04 €
0,03 € – 0,05 €
|
530 M | 1 |
| FY2028 |
-0,02 €
-0,02 € – -0,01 €
|
430 M | 1 |
Points Clés
Revenue grew 13,76% annually over 5 years — strong growth
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -66,29M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,44%
Capital efficient — spends only 1,56% of revenue on capex
Croissance
Revenue Growth (5Y)
13,76%
Revenue (1Y)22,20%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-27,66%
ROIC-23,07%
Net Margin-64,85%
Op. Margin-69,36%
Sécurité
Debt / Equity
0,09
Current Ratio3,56
Interest Coverage-55,46
Valorisation
P/E Ratio
-11,09
P/B Ratio3,48
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22,20% | Revenue Growth (3Y) | 14,87% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13,76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 223,86M | Net Income (TTM) | -145,18M |
| ROE | -27,66% | ROA | -23,33% |
| Gross Margin | 58,64% | Operating Margin | -69,36% |
| Net Margin | -64,85% | Free Cash Flow (TTM) | -66,29M |
| ROIC | -23,07% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 3,56 |
| Interest Coverage | -55,46 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -11,09 | P/B Ratio | 3,48 |
| P/S Ratio | 7,19 | PEG Ratio | 1,35 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,61B | Enterprise Value | 1,47B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 223,86M | 183,19M | 169,67M | 198,60M | 133,66M |
| Net Income | -145,18M | -146,19M | -154,51M | -91,03M | -167,61M |
| EPS (Diluted) | -0,15 | -0,16 | -0,19 | -0,11 | -0,20 |
| Gross Profit | 131,28M | 105,40M | 90,48M | 123,81M | 73,20M |
| Operating Income | -155,27M | -152,33M | -168,61M | -98,48M | -164,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 622,40M | 742,05M | 777,06M | 823,89M | 841,87M |
| Total Liabilities | 159,17M | 155,71M | 133,21M | 130,33M | 137,89M |
| Shareholders' Equity | 463,22M | 586,34M | 643,85M | 693,56M | 703,98M |
| Total Debt | 41,49M | 45,96M | 41,66M | 34,10M | 24,80M |
| Cash & Equivalents | 181,07M | 199,52M | 220,54M | 356,78M | 487,84M |
| Current Assets | 419,93M | 520,10M | 447,18M | 638,00M | 750,61M |
| Current Liabilities | 117,98M | 111,49M | 89,20M | 91,54M | 105,05M |